Excess mortality during the SARS-CoV-2 pandemic in the City of Frankfurt/Main, Germany, in 2020 and 2021, adjusted for age trends and pandemic phases

Aims: Excess mortality during the SARS-CoV-2 pandemic has been studied in many countries. Accounting for population aging has important implications for excess mortality estimates. We show the importance of adjustment for age trends in a small-scale mortality analysis as well as the importance of analysing different pandemic phases for mortality in an urban population. Methods: Population data for Frankfurt/Main for 2016–2021 were obtained from the Municipal Office of Statistics, City of Frankfurt/Main. Mortality data from 2016 to 2021 were provided by the Hessian State Authority. For standardized mortality ratios (SMR=observed number of deaths divided by the expected number of deaths), the expected number of deaths was calculated in two ways: For SMRcrude, the mean mortality rate from the years 2016–2019 was multiplied by the total number of residents in 2020 and 2021 separately. For SMRadjusted, this procedure was performed separately for five age groups, and the numbers of expected deaths per age group were added. Results: SMRcrude was 1.006 (95% CI: 0.980–1.031) in 2020, and 1.047 (95% CI: 1.021–1.073) in 2021. SMRadjusted was 0.976 (95% CI: 0.951–1.001) in 2020 and 0.998 (95% CI: 0.973–1.023) in 2021. Excess mortality was observed during pandemic wave 2, but not during pandemic waves 1 and 3. Conclusion: Taking the aging of the population into account, no excess mortality was observed in Frankfurt/Main in 2020 and 2021. Without adjusting for population aging trends in Frankfurt /Main, mortality would have been greatly overestimated.

[1]  W. Maier,et al.  Area Deprivation and COVID-19 Incidence and Mortality in Bavaria, Germany: A Bayesian Geographical Analysis , 2022, Frontiers in Public Health.

[2]  Richard van Noorden.  COVID death tolls: scientists acknowledge errors in WHO estimates , 2022, Nature.

[3]  M. Levitt,et al.  Comparison of pandemic excess mortality in 2020–2021 across different empirical calculations , 2022, Environmental Research.

[4]  V. Rousson,et al.  Mortality in Switzerland in 2021 , 2022, medRxiv.

[5]  P. Hallal,et al.  The Need to Use Mortality, and Not Case-Fatality, to Compare COVID-19 Deaths Worldwide , 2022, International journal of preventive medicine.

[6]  U. Heudorf,et al.  Die SARS-CoV-2-Pandemie in Altenpflegeheimen: Erkenntnisse und Analysen in Frankfurt am Main von März 2020 bis September 2021 , 2022, Das Gesundheitswesen.

[7]  Reed J. D. Sorensen,et al.  Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020–21 , 2022, The Lancet.

[8]  U. Mansmann,et al.  Regionale und zeitliche Trends der SARS-CoV-2 assoziierten Sterblichkeit in Bayern: Eine altersstratifizierte Analyse über 5 Quartale für Personen ab 50 Jahren , 2022, Das Gesundheitswesen.

[9]  U. Mansmann,et al.  [Regional and Temporal Trends in SARS-CoV-2-Associated Mortality in Bavaria: An Age-Stratified Analysis Over 5 Quarters for Persons Aged 50 and Older]. , 2022, Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)).

[10]  M. Hashizume,et al.  Excess deaths from COVID-19 in Japan and 47 prefectures from January through June 2021 , 2021, Public Health.

[11]  Michael Höhle,et al.  On assessing excess mortality in Germany during the COVID-19 pandemic , 2021, AStA Wirtschafts und Sozialstatistisches Arch..

[12]  S. Helleringer,et al.  Commentary: Measuring excess mortality due to the COVID-19 pandemic: progress and persistent challenges , 2021, International journal of epidemiology.

[13]  M. Blettner,et al.  Erklärbarkeit der altersadjustierten Übersterblichkeit mit den COVID-19-attribuierten Sterbefällen von Januar 2020 bis Juli 2021 , 2021, Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz.

[14]  M. Blettner,et al.  Association of COVID-19 mortality with COVID-19 vaccination rates in Rhineland-Palatinate (Germany) from calendar week 1 to 20 in the year 2021: a registry-based analysis , 2021, European Journal of Epidemiology.

[15]  Takehiko I. Hayashi,et al.  Reduced mortality during the COVID-19 outbreak in Japan, 2020: a two-stage interrupted time-series design , 2021, International journal of epidemiology.

[16]  J. Koch,et al.  STIKO-Empfehlung zur COVID-19-Auffrischimpfung mit einem mRNA-Impfstoff für Personen ≥ 70 Jahre und bestimmte Indikationsgruppen sowie Empfehlung zur Optimierung der Grundimmunisierung mit einem mRNA-Impfstoff nach vorausgegangener Impfung mit der COVID-19 Vaccine Janssen und die dazugehörige wissen , 2021 .

[17]  Ständige Impfkommission.  Beschluss der STIKO zur 10. Aktualisierung der COVID-19-Impfempfehlung , 2021 .

[18]  J. V. Groß,et al.  Before, During, and After the First Wave of COVID-19: Mortality Analyses Reveal Relevant Trends in Germany and its States until June 2020 , 2021, Das Gesundheitswesen.

[19]  K. Jöckel,et al.  Excess mortality due to Covid-19? A comparison of total mortality in 2020 with total mortality in 2016 to 2019 in Germany, Sweden and Spain , 2021, PloS one.

[20]  C. Demetriou,et al.  Excess all-cause mortality and COVID-19-related mortality: a temporal analysis in 22 countries, from January until August 2020 , 2021, International journal of epidemiology.

[21]  Philip Lewis,et al.  COVID-19: Heterogeneous Excess Mortality and “Burden of Disease” in Germany and Italy and Their States and Regions, January–June 2020 , 2021, Frontiers in Public Health.

[22]  S. Petti,et al.  Covid-19, non-Covid-19 and excess mortality rates not comparable across countries , 2021, Epidemiology and Infection.

[23]  V. Rousson,et al.  A first analysis of excess mortality in Switzerland in 2020 , 2021, medRxiv.

[24]  M. Blettner,et al.  Gender specific excess mortality in Italy during the COVID-19 pandemic accounting for age , 2021, European Journal of Epidemiology.

[25]  U. Heininger,et al.  Beschluss und Wissenschaftliche Begründung der Ständigen Impfkommission (STIKO) für die COVID-19-Impfempfehlung , 2020 .

[26]  T. Erren,et al.  COVID-19: Wie änderte sich die Sterblichkeit? – Mortalität von Frauen und Männern in Deutschland und seinen Bundesländern bis Oktober 2020 , 2020, DMW - Deutsche Medizinische Wochenschrift.

[27]  C. Signorelli,et al.  Doubled mortality rate during the COVID-19 pandemic in Italy: quantifying what is not captured by surveillance , 2020, Public Health.

[28]  U. Heudorf,et al.  COVID-19 in long-term care facilities in Frankfurt am Main, Germany: incidence, case reports, and lessons learned , 2020, GMS hygiene and infection control.

[29]  U. Heudorf,et al.  Sars-Cov-2 in children – insights and conclusions from the mandatory reporting data in Frankfurt am Main, Germany, March–July 2020 , 2020, GMS hygiene and infection control.

[30]  K. Jöckel,et al.  Excess mortality due to COVID-19 in Germany , 2020, Journal of Infection.

[31]  A. Majeed,et al.  Excess mortality: the gold standard in measuring the impact of COVID-19 worldwide? , 2020, Journal of the Royal Society of Medicine.

[32]  A. Gasparrini,et al.  Excess mortality during the COVID-19 outbreak in Italy: a two-stage interrupted time series analysis , 2020, medRxiv.

[33]  Denisa Bojkova,et al.  Evidence of SARS-CoV-2 Infection in Returning Travelers from Wuhan, China , 2020, The New England journal of medicine.

[34]  A. Andreano,et al.  Assessment of the Overall Mortality during the COVID-19 Outbreak in the Provinces of Milan and Lodi (Lombardy Region, Northern Italy). , 2020, Epidemiologia & Prevenzione.